版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
MyastheniaGravis
重癥肌無力
(seeP341~346)YANYONGDep.ofNeurology,the1stHospital,ChongqingUniversityofMedicalScienceMyastheniaGravis
重癥肌無1
The
myastheniagravis(MG,重癥肌無力)isa
neuromuscular-transmissiondisorders神經(jīng)肌肉傳遞障礙,and
anacquiredimmunological獲得性免疫disorder(probablyimmunemediated),ofunknowncause,inwhichantibodiesaredirectedagainstthepostsynaptic突觸后
acetylcholine乙酰膽堿receptor(AChR).Thisresultsinweaknessandfatigabilityofskeletalmusclegroups;themostcommonlyaffectedmusclesaretheproximallimbs肢體近端
andocularandbulbar眼和延髓muscles.Themyastheniagravi2Myopathicdisorders肌病includesskeletalmusclesbygene,Inflammation,Metabolicortoxicity:Musculardystrophies肌營養(yǎng)不良:Duchenne’肌營養(yǎng)不良,Becker’sCongenitalmyopathies先天性肌病:mitochondrial肌病、肌管肌病等Myotonicdisorders
肌強(qiáng)直Inflammatorymyopathies炎癥性肌病AIDSMetabolicmyopathies:Hypo-hyperkalemia,osteomalacia等Endocrinemyopathies:Hyper-orhypothyroidism等AlcoholicmyopathiesDrug-inducedmyopathies:corticosteroids,certainβ-blockers,chloroquine,clofibrate,emetrine,colchicine,andsoon.Myoglobinuria肌紅蛋白尿:bymuscleinjuryorischemia,Neuromuscularjunction:MG,lambert-EatonsyndromeMyopathicdisorders肌病inclu3
A.HowdooccurtheMG?Inmotornerves,whenthestimulusreachestheendofthenerveterminalacetylcholine(Ach)isreleasedfromvesiclesviavoltage-gatedcalciumchannels.TheAchcrossesthesynapticcheftandbindsAchRsonthepostsynapticmuscleend-platemembrane.Thisresultsindepolarizationandsubsequentcontractionofmuscle.TheAchisthenbrokendownbyacetyl-cholinesterase,whichisboundtothebasallaminainthesynapticfolds.
A.HowdooccurtheMG4
A.HowdooccurtheMG?TheMGresultsfromtheAchdecreasedbyacetylcholinesteraseoverdoseorthesensitivereducedoftheAchreceptors.
A.HowdooccurtheMG?5
B.Clinicalmanifestation
1.MGcanoccuratanyage.Therearetwopeaksofincidence
forMG,splitbyageandsex:a.Youngwomen(20~40yrs),whotendtohaveanacute,severelyfluctuating,moregeneralizedcondition,withincreasedassociationwithHLA-B8andHLA-DR3.andmorecommoninfemalesthanmales.
Thereisanassociatedabnormalityofthethymus胸腺inpatientswithMG.Thymichyperplasic增生isfoundin80%ofpatientsbelowtheageof40years.B.Clinicalmanifestat6
b.Oldermen(40-75yrs),whotendtohaveamoreoculobulbarpresentationandthymoma,andmorecommoninmalesthanfemales.In10%~20%ofallpatientswithmyastheniagravis,athymictumor胸腺腫瘤(thymoma)isfound,theincidenceincreasingwithage.Inpatientswiththymoma,antibodiestostriated橫紋肌抗體musclemayalsobefound.b.Oldermen(40-75yrs),w72.ClinicalfeaturesTheclinicalfeaturesofMGischaracterizedbyfluctuatingweakness(mildatmorningandsevereatevening晨輕暮重
orwhichrelieveafterrestandworseafterexerciseoraction)andeasyfatigability易疲勞
ofvoluntarymuscles.
Theeasyfatigabilitycausefluctuatingweakness波動(dòng)性無力.Themostcommonlyaffectedmusclesaretheproximallimbs肢體近端
andcranialallocatingmusclessuchasocularandbulbar.MG可累及全身骨骼肌,但最常累及的是四肢近端肌群和腦神經(jīng)支配的肌肉(如眼外肌和延髓肌肉).2.Clinicalfeatures8
Fatigabilitytest疲勞試驗(yàn)
Fatigabilitycanbedemonstratedbyexercisingaffectedmuscles,e.g.letpatientslookupwardsorlookingatceilingforafewsecondstheptosis瞼下垂willbecomeapparent.Similarmaneuver手法canbecarriedoutfortheproximallimbmuscles,suchaslookingatlateral,verticalgazeorreadingfor2~3minsormovinglimbs.
93.PresentingsymptomsinMGSymptomspercentageofpatientsDiplopia復(fù)視41Ptosis眼瞼下垂25Dysarthria構(gòu)音困難16Lowerextremityweakness13Generalizedweakness11Dysphagia吞咽困難10Upperextremityweakness7Masticatoryweakness咀嚼無力7HerrmannCJ.WestJMed1985:142:7973.Presentingsymptoms10
C.Clinicclassification(P343)Ⅰ.Ocularmyasthenia(15%~20%)眼肌型MGⅡA.Mildgeneralizedmyastheniawithslowprogression;nocrisis;drug-responsive(30%)緩慢進(jìn)展的輕度全身型,無危象ⅡB.Moderatelyseveregeneralizedmyasthenia;severeskeletalandbulbarinvolvementbutnocrisis;drugresponselessthansatisfactory(25%)中重度全身型,嚴(yán)重累及骨骼肌和延髓肌但無危象,藥物治療不滿意Ⅲ.Acutefulminatingmyasthenia;rapidprogressionofseveresymptomswithrespiratorycrisisandpoordrugresponse;highincidenceofthymoma;highmortality(15%)急性爆發(fā)性MG,快速進(jìn)展伴呼吸危象,藥物效差,高胸腺瘤死亡率Ⅳ.Lateseveremyasthenia;symptomssameasⅢ,butresultingfromsteadyprogressionover2yrfromclassⅠtoⅡ(10%).晚發(fā)型重癥MG,癥狀同Ⅲ,但從Ⅰ到Ⅱ穩(wěn)緩進(jìn)超2年C.Clinicc11
D.Diagnosis
Inpatientswhopresentwithchangeable(fluctuating)diplopia,typicalmyasthenicfacies,unequallydroopingeyelids,difficultyinspeaking
orswallowing,orweaknessofthelimbs----thediagnosiscanhardlybeoverlooked.Ifthosesymptomsareatfirstmildandinconstant,youcandofatigabilitytestfor
patients.Ifthediagnosisremainsindoubt,themeasurementofspecificexaminationsarenecessary.D.Diagno12
Diagnostictest1.Repeatingnerveelectricstimulation(RNES重復(fù)電刺激):Impairedneuromusculartransmissioncanbedetectedelectrophysiologicallybyadecrementalresponseofmuscletorepetitivesupramaximalstimulation(at2or3Hz)ofitsmotornerve,butnormalfindingsdonotexcludethediagnosis.2.Singlefiberelectromyography(SFEMG單纖維肌電圖)showsincreasedvariabilityintheintervalbetweentwomusclefiberactionpotentialfromthesamemotorunitinclinicallyweakmuscles.Diagnostictest133.Acetylcholinereceptorantibody:乙酰膽堿受體抗體
ThehighlyspecificAchRantibodyispresentintheserumofupto80%-90%ofpatientswithgeneralizedMG.4.Thymus胸腺imaging:ItisalwaysessentialtoimagethechestwithX-ray,CTorMRI,forthepresenceofthymichyperplasia胸腺增生orthymoma胸腺腫瘤,asremovalofahyperplasicthymusimprovestheconditioninmanypatients.3.Acetylcholinereceptoranti145.Neostigmine新斯的明
test:1.0mgofneostigminecanbegivenintramuscularly,witharesponsethatlastsforabout2hours.6.Tensilon(edrophonium騰喜龍)test:Tensilonisgiveniv.inadoseof10mg(1ml),ofwhich2mgisgiveninitiallyandtheremaining8mgabout30secondslaterifthetestdoseiswelltolerated.InMG,thereisanobviousimprovementinthestrengthofweakmusclesthatlastsforabout5minutes.Onlymildmuscarinic毒覃堿effects(pallor,nausea,vomiting,bowel,activation,sweating,salivation)5.Neostigmine新斯的明test:15
Differentialdiagnosis1.Lambert-Eatomsyndrome肌無力綜合癥Torepetitivesupramaximalstimulation(at10Hz)ofitsmotornerve,withcancerusually2.Oculardystrophies眼肌型肌營養(yǎng)不良
prognosticworse,nofluctuatingweakness,Tensilonandfatigabilitytest(-)3.Polymyositis多發(fā)性肌炎
Itisoftenassociatedwithmusclepain,nofluctuatingweakness.theserumCKisgenerallyelevated.Differentialdiagnosis16
E.
Treatment1.Anticholinesterasedrugs抗膽堿酯酶藥物AChD:
Pyridostigminebromide吡啶斯的明—atdosesindividuallydeterminedbutusuallybetween60mg~120mg,tid~qid.Smalldosesofatropinemayattenuatesideeffectssuchasbowelhypermotilityorhypersalivation.Mysuranandneostigminebromidehasnotbeusednow.E.Treatment172.Corticosteroids:
Corticosteroids
providethemainstayofimmuno-suppressivetreatment.Theysucceedin70%ofpatients,butmustbeincreasedslowly.Methylprednisolone-1000mg,iv.qd.3~5d;Prednisolone-1~2mg/kg(60~80mg),po.qd/morning;2weeks,thengraduallyreduced,sustainedover1year.Azathioprine硫唑嘌呤:2~3mg/kg/d.CyclosporineA環(huán)孢素A:6mg.kg.dx12mons2.Corticosteroids:183.Plasmapheresis:
Itissometimesusedespeciallyduringanacuteexacerbationorwhenthereisrespiratoryinvolvement.4.Thymectomy:Itsbeneficialeffect70%forthymomaorhyperplasicthymus,maynotbeevidentimmediately.5.Medications
ThatimpairneuromusculartransmissionshouldbeavoidedsuchasQuinine,Aminoglycosides氨基糖甙類,Phenobarbital苯巴比妥,Diazepam安定,andsoon.3.Plasmapheresis:19
F.
CrisisCrisis危象—ArapiddeteriorationoftheMGitself,canbringtherespiratoryfailure呼吸衰竭
andseverequadriparesis四肢癱瘓.
1.Myastheniccrisis肌無力危象:Itisamostcommontype,anticholinesterasedrugs(AChD)arenotenough.WehavetoincreasetheAChDdoseiftheedrophonium騰喜龍testispositive.F.Crisis202.Cholinergiccrisis膽堿能危象:ItisoftenexcessoftheAChD.Overmedicationcanledtoincreasedweakness.StoppingAChDimmediately,withthemechanicalventilation機(jī)械通氣,thengraduallymodifythedosesofAChDwhenallAChDclearoutfromthebody.3.Brittlecrisis反拗性危象:TheresponsetoAChDispoor,ofunknowncause.StoppingAChDimmediately,withthemechanicalventilation,thengraduallymodifythedosesofAChDifresponsewelltoAChDincourseoftime.2.Cholinergiccrisis膽堿能危象:I21
G.Prognosis
Mostpatientscanbemanagedsuccessfullywithdrugtreatment.Thediseasemayhaveafataloutcomebecauseofrespiratorycomplicationssuchasaspirationpneumonia.G.Prognosi22
Atypicalcase
Awoman,32yrsold.Shewasadmittedinhospitalwithsymmetricallyweaknessoflimbsforamonth,theweaknessismildatmorningandsevereatevening,andthemoresevereontheproximallimbs.Shehashaddiplopiafor4dandmilddysphagia2days.It’snormalsphincter.TheexaminationofNSshowedthat:wakefulness,alitterdysarthria,milddysphagia.Themotorabnormalofbilateraleyeballanddiplopia,thepalsyofbilateralpalata.Therearelow-gradeofmuscletoneanddecreasedtendonreflexonfourlimbs.Theproximalmuscularstrengthoflimbsis4gradeand5gradeondistal.Thepathologicreflexesaredeficit.Therearenormalsensory.
對此患者,①最可能的診斷是什么?②提出應(yīng)該完成那些主要的檢查?③應(yīng)主要與哪些疾病鑒別?④治療過程中會(huì)出現(xiàn)那些危險(xiǎn)?Atypicalcase23Keypoints
1.Classificationofsensory2.Sensorypathway(痛溫覺、觸覺和深感覺傳導(dǎo)3種通路)3.Thelocationofsensorydisorders4.Locationandlaminationofsensorypathwaysinthespinalcord5.
Thecompriseofmotorsystem重點(diǎn)是錐體系統(tǒng)6.Thefeatureoflower/upperneurondisorders7
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2026年哈爾濱職業(yè)技術(shù)學(xué)院單招職業(yè)技能測試題庫及答案詳解1套
- 2026年江西環(huán)境工程職業(yè)學(xué)院單招職業(yè)技能考試題庫及完整答案詳解1套
- 2026年廣西經(jīng)濟(jì)職業(yè)學(xué)院單招職業(yè)適應(yīng)性測試題庫及完整答案詳解1套
- 2025年系統(tǒng)管理員年度工作總結(jié)與2026年度工作計(jì)劃
- 2026年柳州鐵道職業(yè)技術(shù)學(xué)院單招職業(yè)傾向性考試題庫及參考答案詳解
- 2026年河南經(jīng)貿(mào)職業(yè)學(xué)院單招職業(yè)適應(yīng)性測試題庫帶答案詳解
- 2026年無錫工藝職業(yè)技術(shù)學(xué)院單招職業(yè)傾向性考試題庫及答案詳解1套
- 2026年浙江省衢州市單招職業(yè)傾向性測試題庫及參考答案詳解
- 2026年臨沂職業(yè)學(xué)院單招職業(yè)傾向性考試題庫及答案詳解一套
- 2026年寧夏石嘴山市單招職業(yè)適應(yīng)性測試題庫參考答案詳解
- 2023版河北高職單招真題匯編與標(biāo)準(zhǔn)模擬-語文
- 刷白 樹干施工方案
- 空氣能熱泵中央熱水系統(tǒng)調(diào)試
- GB/T 45542-2025工業(yè)鍋爐綜合能效評(píng)價(jià)技術(shù)規(guī)范
- 下肢淋巴水腫的管理實(shí)踐
- QC提高高速公路鐓粗直螺紋鋼筋接頭驗(yàn)收合格率QC成果
- JJF2085-2023低頻角加速度臺(tái)校準(zhǔn)規(guī)范
- 北京麥田房產(chǎn)合同范本
- 《校園欺凌現(xiàn)象與學(xué)校社會(huì)工作干預(yù)的探索》14000字論文
- 交款合同范本
- 安全生產(chǎn)法律法規(guī)匯編(2025版)
評(píng)論
0/150
提交評(píng)論